True Leaf is a plant-forward wellness brand for people and their pets. Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc.
True Leaf Med
True Leaf Medicine Inc. is in the final stages of approval to become a licensed producer of federally-approved medicinal cannabis for the Canadian market. The license is subject to a Health Canada inspection to allow for the production, manufacture, and distribution of cannabis products upon the completion of True Leaf Campus: the company’s cannabis cultivation facility being built in Lumby, British Columbia. Construction is expected to be completed in fall 2018.
True Leaf Pet
Established in 2015, True Leaf Pet Inc. is one of the first companies to market hemp-based products for pets worldwide. The company is initially marketing a line of hemp-seed based supplements for pets. True Hemp™ chews, dental sticks, and supplement oils are sold in more than 1,800 stores across North America and Europe.
True Leaf’s stock is publicly-traded on three exchanges:
- Issued & Outstanding: 95,269,059
- Reserved for Issuance: 11,547,652
100 University Avenue
8th Floor Toronto, ONT
295 Madison Avenue 18th Floor
New York, NY 10017
Davidson & Company, LLP
1200-609 Granville St. Vancouver, BC V7Y 1G6
Recent Capital Markets Transactions
Regulation A+ Offering
In February 2017, the Company filed an offering statement on Form 1-A together with certain other offering materials with the United States Securities and Exchange Commission (the “SEC”) in order to undertake a Regulation A+ crowdfunding campaign. In subsequent months, the Company responded to the SEC’s comments on the offering materials, and on November 21, 2017 the SEC issued a notice of qualification for the offering statement.
The use of Regulation A+ allowed the Company to offer and sell its common shares to public retail investors as well as traditional accredited and institutional investors. The Regulation A+ crowdfunding campaign commenced November 2017 and closed for non-Canadian investors on January 22, 2018. The offering raising $10,000,000 in gross proceeds, consisting of 14,285,715 common shares of the Company at a purchase price of $0.70 per share. On the same terms as the Offering, the Company closed a concurrent Canadian private placement on January 24, 2018 of 5,788,078 common shares raising an aggregate total of $4,051,655.
True Leaf is the first Canadian-listed company to conduct a successful Regulation A+ offering.
Investing in our Common Stock involves a high degree of risk. The company cannot predict the extent to which an active market for its Common Stock will develop or be sustained after this offering, or how the development of such a market might affect the market price of its common stock. Investors in this offering will experience immediate and substantial dilution and market price of the Company’s common stock may fluctuate. For a complete discussion of risks, please refer to the Form 1-A. The offering is being made only by means of an offering circular. An offering statement on Form 1-A relating to these securities has been qualified by the Securities and Exchange Commission. You may obtain a copy of the final offering circular below. This document contains forward-looking statements reflecting current expectations that involve risks and uncertainties. These forward-looking statements include statements regarding commercialization plans, projected timelines, etc. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the section entitled "Risk Factors" and elsewhere in the offering circular. This document shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No money or other consideration is being solicited in connection with this document, and if sent in response, will not be accepted. Any person's indication of interest involves no obligation or commitment of any kind.